Evidence map›Paper›PMID 32089742›Full record

ArticleTheranostics2020

Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.

Jin Fang, Bin Zhang, Shuo Wang, Yan Jin, Fei Wang, Yingying Ding, Qiuying Chen, Liting Chen, Yueyue Li, Minmin Li and 5 more

Abstract read
In one paragraph

Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jin FangMedical Imaging Center, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Bin ZhangMedical Imaging Center, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Shuo WangBeijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Medicine, Beihang University, Beijing, 100191, China.
Yan JinDepartment of Radiology, the Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming, Yunnan, 650031, China.
Fei WangMedical Imaging Center, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Yingying DingDepartment of Radiology, the Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming, Yunnan, 650031, China.
Qiuying ChenMedical Imaging Center, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Liting ChenMedical Imaging Center, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Yueyue LiMedical Imaging Center, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Minmin LiMedical Imaging Center, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Zhuozhi ChenMedical Imaging Center, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Lizhi LiuSun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
Zhenyu LiuCAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.
Jie TianBeijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Medicine, Beihang University, Beijing, 100191, China.
Shuixing ZhangMedical Imaging Center, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pre-treatment survival prediction plays a key role in many diseases. We aimed to determine the prognostic value of pre-treatment Magnetic Resonance Imaging (MRI) based radiomic score for disease-free survival (DFS) in patients with early-stage (IB-IIA) cervical cancer.

Indexed as

AdultBiomarkersDisease-Free SurvivalFemaleHumansHysterectomyKaplan-Meier EstimateLymphatic MetastasisMagnetic Resonance ImagingMiddle AgedNeoplasm StagingPrognosisProportional Hazards ModelsRetrospective StudiesROC CurveUterine Cervical NeoplasmsBiomarkerscervical cancerdisease-free survivalmagnetic resonance imagingradiomics

Identifiers

PMID32089742
PMCPMC7019161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.